Loading…

Inflammatory disease in HLA-B27 transgenic rats

A spontaneous inflammatory disease in rats transgenic for HLAB27 resembles the B27‐associated human spondyloarthropathies, Colitis and arthritis, the two most important features, require T cells, gut bacteria, and high expression of B27 in bone marrow‐derived cells, Control rats with HLA‐B7 remain h...

Full description

Saved in:
Bibliographic Details
Published in:Immunological reviews 1999-06, Vol.169 (1), p.209-223
Main Authors: Taugor, Joel D., Maika, Shanna D., Satumtira, Nimman, Dorris, Martha L., McLean, Ian Lochlan, Yanagisawa, Hiromi, Sayad, Alain, Stagg, Andrew J., Fox, Graham M., Le O'Brein, Anne, Rehman, Muhammad, Zhou, Ming, Weiner, Allison L., Splawski, Judy B., Richardson, James A., Hammer, Robert E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5059-b7c6118f4d59b90b0042bb67f7d0d385ff73aba9463726d32ff41322ca54856c3
cites cdi_FETCH-LOGICAL-c5059-b7c6118f4d59b90b0042bb67f7d0d385ff73aba9463726d32ff41322ca54856c3
container_end_page 223
container_issue 1
container_start_page 209
container_title Immunological reviews
container_volume 169
creator Taugor, Joel D.
Maika, Shanna D.
Satumtira, Nimman
Dorris, Martha L.
McLean, Ian Lochlan
Yanagisawa, Hiromi
Sayad, Alain
Stagg, Andrew J.
Fox, Graham M.
Le O'Brein, Anne
Rehman, Muhammad
Zhou, Ming
Weiner, Allison L.
Splawski, Judy B.
Richardson, James A.
Hammer, Robert E.
description A spontaneous inflammatory disease in rats transgenic for HLAB27 resembles the B27‐associated human spondyloarthropathies, Colitis and arthritis, the two most important features, require T cells, gut bacteria, and high expression of B27 in bone marrow‐derived cells, Control rats with HLA‐B7 remain healthy. Most rats with HLA‐Cw6 (associated with psoriasis vulgaris) remain healthy; a minority develop mild and transient disease. Rats with a mutant B27 with a Cys67←Ser substitution resemble wild‐type B27 transgenics, but with a lower prevalence of arthritis. A similar phenotype is seen in B2 7 rats co‐expressing a viral peptide that binds B27. Disease‐prone LEW but not F344 B27 rats develop high serum IgA levels concurrent with disease progression. Colitis is associated with high interferon‐y, arthritis with high interleukin‐6. Disease is similar in B27 LEW, F344, and PVG rats, but the DA background is protective. Conclusions: The spondyloarthropathy‐like disease in rats is specific for HLA‐B27 but does not require Cys67. Arthritis but not colitis is particularly sensitive to B27 peptide‐binding specificity. Genetic background exerts a strong influence, but some phenotypic differences exist between permissive strains that do not influence disease susceptibility The data favor a role for B27 peptide presentation in arthritis, but other mechanisms to explain the role of B27 have not been excluded.
doi_str_mv 10.1111/j.1600-065X.1999.tb01317.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69972238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69972238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5059-b7c6118f4d59b90b0042bb67f7d0d385ff73aba9463726d32ff41322ca54856c3</originalsourceid><addsrcrecordid>eNqVkE1LwzAYgIMoOj_-ghQP3tq9SZqk8SCo6BxMZX7fQtom0tl2mnS4_XtbOsSbmEsOed4nvA9CRxgi3J7hLMIcIATOXiMspYyaFDDFIlpuoMHP0yYaAAYWkkTyHbTr_QwAC0ribbSDIWbAsByg4bi2pa4q3czdKsgLb7Q3QVEH15Oz8JyIoHG69m-mLrLA6cbvoy2rS28O1vceerq6fLy4Did3o_HF2STMWrEMU5FxjBMb50ymElKAmKQpF1bkkNOEWSuoTrWMORWE55RYG2NKSKZZnDCe0T103Hs_3PxzYXyjqsJnpix1beYLr7iUghCa_Am2KwvBRQee9GDm5t47Y9WHKyrtVgqD6rqqmeriqS6e6rqqdVe1bIcP178s0srkv0b7kC1w2gNfRWlW_1Cr8c09gU4Q9oLCN2b5I9DuXfF2BaZebkdqNJ1K8fB8riT9Bn7ZlQE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17377678</pqid></control><display><type>article</type><title>Inflammatory disease in HLA-B27 transgenic rats</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Taugor, Joel D. ; Maika, Shanna D. ; Satumtira, Nimman ; Dorris, Martha L. ; McLean, Ian Lochlan ; Yanagisawa, Hiromi ; Sayad, Alain ; Stagg, Andrew J. ; Fox, Graham M. ; Le O'Brein, Anne ; Rehman, Muhammad ; Zhou, Ming ; Weiner, Allison L. ; Splawski, Judy B. ; Richardson, James A. ; Hammer, Robert E.</creator><creatorcontrib>Taugor, Joel D. ; Maika, Shanna D. ; Satumtira, Nimman ; Dorris, Martha L. ; McLean, Ian Lochlan ; Yanagisawa, Hiromi ; Sayad, Alain ; Stagg, Andrew J. ; Fox, Graham M. ; Le O'Brein, Anne ; Rehman, Muhammad ; Zhou, Ming ; Weiner, Allison L. ; Splawski, Judy B. ; Richardson, James A. ; Hammer, Robert E.</creatorcontrib><description>A spontaneous inflammatory disease in rats transgenic for HLAB27 resembles the B27‐associated human spondyloarthropathies, Colitis and arthritis, the two most important features, require T cells, gut bacteria, and high expression of B27 in bone marrow‐derived cells, Control rats with HLA‐B7 remain healthy. Most rats with HLA‐Cw6 (associated with psoriasis vulgaris) remain healthy; a minority develop mild and transient disease. Rats with a mutant B27 with a Cys67←Ser substitution resemble wild‐type B27 transgenics, but with a lower prevalence of arthritis. A similar phenotype is seen in B2 7 rats co‐expressing a viral peptide that binds B27. Disease‐prone LEW but not F344 B27 rats develop high serum IgA levels concurrent with disease progression. Colitis is associated with high interferon‐y, arthritis with high interleukin‐6. Disease is similar in B27 LEW, F344, and PVG rats, but the DA background is protective. Conclusions: The spondyloarthropathy‐like disease in rats is specific for HLA‐B27 but does not require Cys67. Arthritis but not colitis is particularly sensitive to B27 peptide‐binding specificity. Genetic background exerts a strong influence, but some phenotypic differences exist between permissive strains that do not influence disease susceptibility The data favor a role for B27 peptide presentation in arthritis, but other mechanisms to explain the role of B27 have not been excluded.</description><identifier>ISSN: 0105-2896</identifier><identifier>EISSN: 1600-065X</identifier><identifier>DOI: 10.1111/j.1600-065X.1999.tb01317.x</identifier><identifier>PMID: 10450519</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Amino Acid Sequence ; Animals ; Animals, Genetically Modified ; Antigen Presentation ; Arthritis - genetics ; Arthritis - immunology ; Cytokines - immunology ; Disease Models, Animal ; histocompatibility antigen HLA ; HLA-B27 Antigen - genetics ; Humans ; Immunity, Cellular ; Immunoglobulin A - blood ; Inflammation - genetics ; Inflammation - immunology ; Mutation ; Peptides - genetics ; Peptides - immunology ; Phenotype ; Rats ; Rats, Inbred Strains ; Spondylitis - genetics ; Spondylitis - immunology</subject><ispartof>Immunological reviews, 1999-06, Vol.169 (1), p.209-223</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5059-b7c6118f4d59b90b0042bb67f7d0d385ff73aba9463726d32ff41322ca54856c3</citedby><cites>FETCH-LOGICAL-c5059-b7c6118f4d59b90b0042bb67f7d0d385ff73aba9463726d32ff41322ca54856c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10450519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taugor, Joel D.</creatorcontrib><creatorcontrib>Maika, Shanna D.</creatorcontrib><creatorcontrib>Satumtira, Nimman</creatorcontrib><creatorcontrib>Dorris, Martha L.</creatorcontrib><creatorcontrib>McLean, Ian Lochlan</creatorcontrib><creatorcontrib>Yanagisawa, Hiromi</creatorcontrib><creatorcontrib>Sayad, Alain</creatorcontrib><creatorcontrib>Stagg, Andrew J.</creatorcontrib><creatorcontrib>Fox, Graham M.</creatorcontrib><creatorcontrib>Le O'Brein, Anne</creatorcontrib><creatorcontrib>Rehman, Muhammad</creatorcontrib><creatorcontrib>Zhou, Ming</creatorcontrib><creatorcontrib>Weiner, Allison L.</creatorcontrib><creatorcontrib>Splawski, Judy B.</creatorcontrib><creatorcontrib>Richardson, James A.</creatorcontrib><creatorcontrib>Hammer, Robert E.</creatorcontrib><title>Inflammatory disease in HLA-B27 transgenic rats</title><title>Immunological reviews</title><addtitle>Immunol Rev</addtitle><description>A spontaneous inflammatory disease in rats transgenic for HLAB27 resembles the B27‐associated human spondyloarthropathies, Colitis and arthritis, the two most important features, require T cells, gut bacteria, and high expression of B27 in bone marrow‐derived cells, Control rats with HLA‐B7 remain healthy. Most rats with HLA‐Cw6 (associated with psoriasis vulgaris) remain healthy; a minority develop mild and transient disease. Rats with a mutant B27 with a Cys67←Ser substitution resemble wild‐type B27 transgenics, but with a lower prevalence of arthritis. A similar phenotype is seen in B2 7 rats co‐expressing a viral peptide that binds B27. Disease‐prone LEW but not F344 B27 rats develop high serum IgA levels concurrent with disease progression. Colitis is associated with high interferon‐y, arthritis with high interleukin‐6. Disease is similar in B27 LEW, F344, and PVG rats, but the DA background is protective. Conclusions: The spondyloarthropathy‐like disease in rats is specific for HLA‐B27 but does not require Cys67. Arthritis but not colitis is particularly sensitive to B27 peptide‐binding specificity. Genetic background exerts a strong influence, but some phenotypic differences exist between permissive strains that do not influence disease susceptibility The data favor a role for B27 peptide presentation in arthritis, but other mechanisms to explain the role of B27 have not been excluded.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Animals, Genetically Modified</subject><subject>Antigen Presentation</subject><subject>Arthritis - genetics</subject><subject>Arthritis - immunology</subject><subject>Cytokines - immunology</subject><subject>Disease Models, Animal</subject><subject>histocompatibility antigen HLA</subject><subject>HLA-B27 Antigen - genetics</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Immunoglobulin A - blood</subject><subject>Inflammation - genetics</subject><subject>Inflammation - immunology</subject><subject>Mutation</subject><subject>Peptides - genetics</subject><subject>Peptides - immunology</subject><subject>Phenotype</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Spondylitis - genetics</subject><subject>Spondylitis - immunology</subject><issn>0105-2896</issn><issn>1600-065X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqVkE1LwzAYgIMoOj_-ghQP3tq9SZqk8SCo6BxMZX7fQtom0tl2mnS4_XtbOsSbmEsOed4nvA9CRxgi3J7hLMIcIATOXiMspYyaFDDFIlpuoMHP0yYaAAYWkkTyHbTr_QwAC0ribbSDIWbAsByg4bi2pa4q3czdKsgLb7Q3QVEH15Oz8JyIoHG69m-mLrLA6cbvoy2rS28O1vceerq6fLy4Did3o_HF2STMWrEMU5FxjBMb50ymElKAmKQpF1bkkNOEWSuoTrWMORWE55RYG2NKSKZZnDCe0T103Hs_3PxzYXyjqsJnpix1beYLr7iUghCa_Am2KwvBRQee9GDm5t47Y9WHKyrtVgqD6rqqmeriqS6e6rqqdVe1bIcP178s0srkv0b7kC1w2gNfRWlW_1Cr8c09gU4Q9oLCN2b5I9DuXfF2BaZebkdqNJ1K8fB8riT9Bn7ZlQE</recordid><startdate>199906</startdate><enddate>199906</enddate><creator>Taugor, Joel D.</creator><creator>Maika, Shanna D.</creator><creator>Satumtira, Nimman</creator><creator>Dorris, Martha L.</creator><creator>McLean, Ian Lochlan</creator><creator>Yanagisawa, Hiromi</creator><creator>Sayad, Alain</creator><creator>Stagg, Andrew J.</creator><creator>Fox, Graham M.</creator><creator>Le O'Brein, Anne</creator><creator>Rehman, Muhammad</creator><creator>Zhou, Ming</creator><creator>Weiner, Allison L.</creator><creator>Splawski, Judy B.</creator><creator>Richardson, James A.</creator><creator>Hammer, Robert E.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>199906</creationdate><title>Inflammatory disease in HLA-B27 transgenic rats</title><author>Taugor, Joel D. ; Maika, Shanna D. ; Satumtira, Nimman ; Dorris, Martha L. ; McLean, Ian Lochlan ; Yanagisawa, Hiromi ; Sayad, Alain ; Stagg, Andrew J. ; Fox, Graham M. ; Le O'Brein, Anne ; Rehman, Muhammad ; Zhou, Ming ; Weiner, Allison L. ; Splawski, Judy B. ; Richardson, James A. ; Hammer, Robert E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5059-b7c6118f4d59b90b0042bb67f7d0d385ff73aba9463726d32ff41322ca54856c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Animals, Genetically Modified</topic><topic>Antigen Presentation</topic><topic>Arthritis - genetics</topic><topic>Arthritis - immunology</topic><topic>Cytokines - immunology</topic><topic>Disease Models, Animal</topic><topic>histocompatibility antigen HLA</topic><topic>HLA-B27 Antigen - genetics</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Immunoglobulin A - blood</topic><topic>Inflammation - genetics</topic><topic>Inflammation - immunology</topic><topic>Mutation</topic><topic>Peptides - genetics</topic><topic>Peptides - immunology</topic><topic>Phenotype</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Spondylitis - genetics</topic><topic>Spondylitis - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taugor, Joel D.</creatorcontrib><creatorcontrib>Maika, Shanna D.</creatorcontrib><creatorcontrib>Satumtira, Nimman</creatorcontrib><creatorcontrib>Dorris, Martha L.</creatorcontrib><creatorcontrib>McLean, Ian Lochlan</creatorcontrib><creatorcontrib>Yanagisawa, Hiromi</creatorcontrib><creatorcontrib>Sayad, Alain</creatorcontrib><creatorcontrib>Stagg, Andrew J.</creatorcontrib><creatorcontrib>Fox, Graham M.</creatorcontrib><creatorcontrib>Le O'Brein, Anne</creatorcontrib><creatorcontrib>Rehman, Muhammad</creatorcontrib><creatorcontrib>Zhou, Ming</creatorcontrib><creatorcontrib>Weiner, Allison L.</creatorcontrib><creatorcontrib>Splawski, Judy B.</creatorcontrib><creatorcontrib>Richardson, James A.</creatorcontrib><creatorcontrib>Hammer, Robert E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Immunological reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taugor, Joel D.</au><au>Maika, Shanna D.</au><au>Satumtira, Nimman</au><au>Dorris, Martha L.</au><au>McLean, Ian Lochlan</au><au>Yanagisawa, Hiromi</au><au>Sayad, Alain</au><au>Stagg, Andrew J.</au><au>Fox, Graham M.</au><au>Le O'Brein, Anne</au><au>Rehman, Muhammad</au><au>Zhou, Ming</au><au>Weiner, Allison L.</au><au>Splawski, Judy B.</au><au>Richardson, James A.</au><au>Hammer, Robert E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inflammatory disease in HLA-B27 transgenic rats</atitle><jtitle>Immunological reviews</jtitle><addtitle>Immunol Rev</addtitle><date>1999-06</date><risdate>1999</risdate><volume>169</volume><issue>1</issue><spage>209</spage><epage>223</epage><pages>209-223</pages><issn>0105-2896</issn><eissn>1600-065X</eissn><abstract>A spontaneous inflammatory disease in rats transgenic for HLAB27 resembles the B27‐associated human spondyloarthropathies, Colitis and arthritis, the two most important features, require T cells, gut bacteria, and high expression of B27 in bone marrow‐derived cells, Control rats with HLA‐B7 remain healthy. Most rats with HLA‐Cw6 (associated with psoriasis vulgaris) remain healthy; a minority develop mild and transient disease. Rats with a mutant B27 with a Cys67←Ser substitution resemble wild‐type B27 transgenics, but with a lower prevalence of arthritis. A similar phenotype is seen in B2 7 rats co‐expressing a viral peptide that binds B27. Disease‐prone LEW but not F344 B27 rats develop high serum IgA levels concurrent with disease progression. Colitis is associated with high interferon‐y, arthritis with high interleukin‐6. Disease is similar in B27 LEW, F344, and PVG rats, but the DA background is protective. Conclusions: The spondyloarthropathy‐like disease in rats is specific for HLA‐B27 but does not require Cys67. Arthritis but not colitis is particularly sensitive to B27 peptide‐binding specificity. Genetic background exerts a strong influence, but some phenotypic differences exist between permissive strains that do not influence disease susceptibility The data favor a role for B27 peptide presentation in arthritis, but other mechanisms to explain the role of B27 have not been excluded.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>10450519</pmid><doi>10.1111/j.1600-065X.1999.tb01317.x</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0105-2896
ispartof Immunological reviews, 1999-06, Vol.169 (1), p.209-223
issn 0105-2896
1600-065X
language eng
recordid cdi_proquest_miscellaneous_69972238
source Wiley-Blackwell Read & Publish Collection
subjects Amino Acid Sequence
Animals
Animals, Genetically Modified
Antigen Presentation
Arthritis - genetics
Arthritis - immunology
Cytokines - immunology
Disease Models, Animal
histocompatibility antigen HLA
HLA-B27 Antigen - genetics
Humans
Immunity, Cellular
Immunoglobulin A - blood
Inflammation - genetics
Inflammation - immunology
Mutation
Peptides - genetics
Peptides - immunology
Phenotype
Rats
Rats, Inbred Strains
Spondylitis - genetics
Spondylitis - immunology
title Inflammatory disease in HLA-B27 transgenic rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A26%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inflammatory%20disease%20in%20HLA-B27%20transgenic%20rats&rft.jtitle=Immunological%20reviews&rft.au=Taugor,%20Joel%20D.&rft.date=1999-06&rft.volume=169&rft.issue=1&rft.spage=209&rft.epage=223&rft.pages=209-223&rft.issn=0105-2896&rft.eissn=1600-065X&rft_id=info:doi/10.1111/j.1600-065X.1999.tb01317.x&rft_dat=%3Cproquest_cross%3E69972238%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5059-b7c6118f4d59b90b0042bb67f7d0d385ff73aba9463726d32ff41322ca54856c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17377678&rft_id=info:pmid/10450519&rfr_iscdi=true